Search - tctmd.com

Displaying 21 - 40 of 964

Sort: Relevancy | Date

News Daily News

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

Todd Neale

July 24, 2025

News Opinion CV Team Dispatch

July 2025 Dispatch for the CV Team

L.A. McKeown

July 24, 2025

News Opinion CV Team Dispatch

June 2025 Dispatch for the CV Team

L.A. McKeown

June 26, 2025

News Daily News

Amylin Analogue Boosts Weight Loss When Added to GLP-1

L.A. McKeown

June 24, 2025

No Change in HF Outcomes When Private Equity Buys the Hospital

News Daily News

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

Michael O'Riordan

June 16, 2025

News Daily News

Liberal Transfusion Strategy for Acute MI and Anemia Doesn’t Impact QoL

Michael O'Riordan

June 06, 2025

News Conference News EuroPCR 2025

‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI

Michael O'Riordan

May 29, 2025

News Conference News EuroPCR 2025

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

L.A. McKeown

May 21, 2025

News Daily News

CV Death Rates in Autoimmune Disorders Waning, but Still Higher in Women

L.A. McKeown

May 14, 2025

News Conference News European Congress on Obesity 2025

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Michael O'Riordan

May 13, 2025

News Conference News European Congress on Obesity 2025

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Michael O'Riordan

May 12, 2025

News Daily News

Another Win for PREVENT, This Time in Older Adults

Yael L. Maxwell

May 06, 2025

News Daily News

Access to GLP-1 Drugs Unequal for US Patients With Obesity

Caitlin E. Cox

May 01, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2025

Caitlin E. Cox

April 30, 2025

News Daily News

AHA Statement Zeroes In On Sleep Health

L.A. McKeown

April 17, 2025

News Daily News

Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM

L.A. McKeown

April 15, 2025

News Daily News

Cardiotoxicity Rare With Common GI Chemotherapy

L.A. McKeown

April 15, 2025

News Conference News ACC 2025

FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints

L.A. McKeown

April 03, 2025

News Conference News ACC 2025

Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP

Michael O'Riordan

April 01, 2025

News Daily News

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Michael O'Riordan

March 26, 2025

Advertisement

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

July 2025 Dispatch for the CV Team

June 2025 Dispatch for the CV Team

Amylin Analogue Boosts Weight Loss When Added to GLP-1

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

Liberal Transfusion Strategy for Acute MI and Anemia Doesn’t Impact QoL

‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

CV Death Rates in Autoimmune Disorders Waning, but Still Higher in Women

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Another Win for PREVENT, This Time in Older Adults

Access to GLP-1 Drugs Unequal for US Patients With Obesity

TCTMD’s Top 10 Most Popular Stories for April 2025

AHA Statement Zeroes In On Sleep Health

Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM

Cardiotoxicity Rare With Common GI Chemotherapy

FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints

Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content